SDM laser effective for CSC

Article

According to recently published data, an 810 nm subthreshold diode micropulse (SDM) laser is effective in the treatment of chronic central serous chorioretinopathy (CSC).

According to recently published data, an 810 nm subthreshold diode micropulse (SDM) laser is effective in the treatment of chronic central serous chorioretinopathy (CSC).

The study, performed by Dr Luiz Roisman et al. (Federal University of Sao Paulo, Brazil), included 15 patients in total who were randomized into two groups to either receive SDM laser treatment or a sham procedure.

Ten patients received SDM laser treatment along the detached area, the remaining five patients received sham treatment. At 3 months follow up, the best-corrected visual acuity (BCVA) was found to be significantly improved in the laser treatment group. All patients allocated to the sham group required treatment after 3 months. Central macular thickness was noted to be better in both groups.

It was concluded that SDM laser treatment was effective in the treatment of chronic CSC without causing any damage to the retina.

For more detailed information please view the abstract in Ophthalmic Surgery, Lasers and Imaging.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.